Amplify by Medtronic May Raise Chance of Cancer, Data Shows
Thursday, November 3, 2011 - 18:00
in Health & Medicine
A study by a Stanford University doctor showed that spinal fusion patients treated with high doses of the bone growth drug Amplify were at greater risk for cancer.